Moore Capital Management, LP Beyond Spring Inc. Transaction History

Moore Capital Management, LP

  • $5.25 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$10.21 - $17.31 $408,400 - $692,400
-40,000 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$9.99 - $16.13 $44,805 - $72,343
-4,485 Reduced 10.08%
40,000 $532,000
Q2 2020

Aug 14, 2020
BUY
$11.21 - $18.15 $274,476 - $444,402
24,485 Added 122.43%
44,485 $671,000
Q1 2020

May 15, 2020
BUY
$9.68 - $18.47 $193,600 - $369,400
20,000 New
20,000 $256,000

Others Institutions Holding BYSI

# of Institutions
22
Shares Held
5.77M
Call Options Held
53.2K
Put Options Held
2.5K
View Full List

About BeyondSpring Inc.

BYSI Quotes by TradingView
  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $91.9M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email